10 research outputs found
Additional file 1 of Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
Additional file 1
Additional file 2 of Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
Additional file 2
Other medication used versus prescribed cannabinoids.
Other medication used versus prescribed cannabinoids.</p
Reported improvement in main condition: comparing prescribed cannabinoids using PGIC scores.
Reported improvement in main condition: comparing prescribed cannabinoids using PGIC scores.</p
MacPhail vs CAMS approximate (%) S8 approval in Jan 2021 for most common indications.
MacPhail vs CAMS approximate (%) S8 approval in Jan 2021 for most common indications.</p
Characteristics of prescribed medicinal cannabis users by cannabinoid product composition.
Characteristics of prescribed medicinal cannabis users by cannabinoid product composition.</p
Most commonly reported side effects in participants receiving prescribed MC.
Most commonly reported side effects in participants receiving prescribed MC.</p
Main reasons for use of prescribed medicinal cannabis users by cannabinoid product production composition.
Main reasons for use of prescribed medicinal cannabis users by cannabinoid product production composition.</p
Driving patterns of participants on prescribed THC vs prescribed CO.
Driving patterns of participants on prescribed THC vs prescribed CO.</p
Additional file 1: of Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol
CONSORT 2010 checklist of information to include when reporting a randomised trial. (PDF 69Â kb